The high flow nasal cannula market size has grown strongly in recent years. It will grow from $6.22 billion in 2025 to $6.79 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing incidence of respiratory disorders, rising hospital admissions for acute respiratory failure, adoption of high-flow oxygen therapy protocols, expansion of intensive care infrastructure, growing clinical awareness of hfnc benefits.
The high flow nasal cannula market size is expected to see strong growth in the next few years. It will grow to $9.64 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing use of hfnc in home care settings, rising demand for portable respiratory support devices, expansion of respiratory care services, growing focus on early intervention therapies, increasing technological advancements in airflow and humidification systems. Major trends in the forecast period include increasing adoption of advanced heated humidification systems, rising use of hfnc in acute care settings, growing preference for non-invasive oxygen therapy, expansion of portable and home-based hfnc solutions, enhanced focus on patient comfort and compliance.
The increasing incidence of asthma and COPD is expected to drive the growth of the high-flow nasal cannula market in the coming years. Asthma is a condition in which the airways in the lungs become inflamed and narrowed, often producing excess mucus. COPD, or chronic obstructive pulmonary disease, encompasses a group of progressive lung conditions that make breathing difficult and worsen over time. High-flow nasal cannula therapy can enhance arterial oxygen levels while reducing heart rate and respiratory rate, making it an effective treatment option for patients experiencing severe bronchial asthma complicated by respiratory failure. High-flow nasal cannula systems help address the growing burden of asthma and COPD by improving oxygen delivery and alleviating respiratory distress in affected individuals. For instance, in June 2025, according to the Office for Health Improvement & Disparities, a UK-based government department, emergency hospital admissions for respiratory diseases in England increased by 7% between the 2022-23 and 2023-24 financial years. Therefore, the rising incidence of asthma and COPD is driving the growth of the high-flow nasal cannula market.
Major companies in the high-flow nasal cannula market are concentrating on advanced products such as the SoftFlow High-Flow Nasal Cannula to better serve their existing customers. The SoftFlow High-Flow Nasal Cannula is a breathing assistance device that provides patients with warm, humidified, oxygen-enriched air through a nasal cannula. For example, in 2024, Fisher & Paykel Healthcare, a New Zealand-based manufacturer and marketer of products and systems for acute and chronic respiratory care, surgery, and obstructive sleep apnea treatment, introduced the Airvo 2 device as part of the Optiflow Nasal High Flow Therapy system. This device delivers heated, humidified air and oxygen at high flow rates, enhancing oxygenation and reducing the work of breathing for patients suffering from COVID-19 and other respiratory ailments. Its optimal humidity levels support mucociliary function and decrease airway dryness, thus improving patient comfort. Furthermore, the device is designed for easy setup and use, making it appropriate for various hospital environments and contributing to better clinical outcomes.
In March 2024, Onymos, a US-based developer of a Features-as-a-Service platform, partnered with Vapotherm, Inc. for an undisclosed amount. Through this partnership, Onymos aims to support Vapotherm in building a secure, end-to-end Internet of Medical Things (IoMT) platform that enhances remote device connectivity, real-time data visualization, and device management capabilities for Vapotherm’s HVT 2 system and future respiratory care products. This collaboration is intended to strengthen Vapotherm’s digital infrastructure, enabling improved monitoring, operational efficiency, and scalability across connected respiratory therapy devices. Vapotherm, Inc. is a US-based medical technology company specializing in high-velocity respiratory therapy solutions, including high-flow nasal cannula systems.
Major companies operating in the high flow nasal cannula market are Air Liquide Medical Systems Pvt. Ltd., Becton Dickinson and Company, Koninklijke Philips N.V., ResMed Inc., Drägerwerk AG & Co. KGaA, Teleflex Incorporated, Medical Dynamics Inc., Fisher & Paykel Healthcare Corporation Limited, Smiths Medical Inc., Vyaire Medical Inc., DeVilbiss Healthcare LLC, Armstrong Medical Ltd, Vapotherm Inc., SunMed LLC, Medin Medical Innovations GmbH, MEK-ICS Co. Ltd., Narang Medical Limited, Breas Medical AB, Bio-Med Devices Inc., Flexicare Medical Ltd., Fairmont Medical Products Pty Ltd, Besmed Health Business Corp., Löwenstein GmbH & Co. KG, Great Group Medical Co. Ltd., TNI Medical AG, Guangdong Pigeon Medical Apparatus Co.LTD, BLS Systems Limited.
North America was the largest region in the high flow nasal cannula market in 2025. The regions covered in the high flow nasal cannula market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the high flow nasal cannula market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the high-flow nasal cannula market by increasing costs of imported electronic controllers, sensors, heating elements, humidification chambers, and medical-grade plastics used in device manufacturing. Hospitals and care facilities in North America and Europe are most affected due to dependence on imported components, while Asia-Pacific faces pricing pressure on export-driven production. These tariffs are raising equipment acquisition costs and impacting procurement budgets. At the same time, they are encouraging regional manufacturing, local assembly of respiratory devices, and innovation in cost-optimized HFNC system designs.
The high flow nasal cannula market research report is one of a series of new reports that provides high flow nasal cannula market statistics, including high flow nasal cannula industry global market size, regional shares, competitors with a high flow nasal cannula market share, detailed high flow nasal cannula market segments, market trends and opportunities, and any further data you may need to thrive in the high flow nasal cannula industry. This high flow nasal cannula market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A high-flow nasal cannula (HFNC) is a medical device designed for delivering a high flow of heated and humidified oxygen-enriched air to patients with respiratory conditions. It comprises a lightweight tube connected to a machine that regulates the flow of air and oxygen. The cannula, placed in the patient's nostrils, administers a continuous stream of warm and moistened air at a higher flow rate compared to traditional oxygen therapy methods.
The primary types of high-flow nasal cannulas include air or oxygen blenders, nasal cannulas, active humidifiers, single-heated tubes, and others. Air-oxygen blenders are medical devices that blend air and oxygen to deliver a precise combination of oxygen and air to patients experiencing breathing difficulties or undergoing anesthesia. These devices find applications in various medical conditions such as acute respiratory failure, chronic obstructive pulmonary disease (COPD), carbon monoxide toxicity, bronchiectasis, sleep apnea, among others. High-flow nasal cannulas are distributed through diverse sales channels, including direct channels, and are utilized by various end-users, including hospitals and clinics, ambulatory care centers, long-term care centers, and others.
The high-flow nasal cannula (HFNC) market consists of sales of flow generators, oxygen blenders, nasal prongs, and humidifiers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The high flow nasal cannula market size is expected to see strong growth in the next few years. It will grow to $9.64 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing use of hfnc in home care settings, rising demand for portable respiratory support devices, expansion of respiratory care services, growing focus on early intervention therapies, increasing technological advancements in airflow and humidification systems. Major trends in the forecast period include increasing adoption of advanced heated humidification systems, rising use of hfnc in acute care settings, growing preference for non-invasive oxygen therapy, expansion of portable and home-based hfnc solutions, enhanced focus on patient comfort and compliance.
The increasing incidence of asthma and COPD is expected to drive the growth of the high-flow nasal cannula market in the coming years. Asthma is a condition in which the airways in the lungs become inflamed and narrowed, often producing excess mucus. COPD, or chronic obstructive pulmonary disease, encompasses a group of progressive lung conditions that make breathing difficult and worsen over time. High-flow nasal cannula therapy can enhance arterial oxygen levels while reducing heart rate and respiratory rate, making it an effective treatment option for patients experiencing severe bronchial asthma complicated by respiratory failure. High-flow nasal cannula systems help address the growing burden of asthma and COPD by improving oxygen delivery and alleviating respiratory distress in affected individuals. For instance, in June 2025, according to the Office for Health Improvement & Disparities, a UK-based government department, emergency hospital admissions for respiratory diseases in England increased by 7% between the 2022-23 and 2023-24 financial years. Therefore, the rising incidence of asthma and COPD is driving the growth of the high-flow nasal cannula market.
Major companies in the high-flow nasal cannula market are concentrating on advanced products such as the SoftFlow High-Flow Nasal Cannula to better serve their existing customers. The SoftFlow High-Flow Nasal Cannula is a breathing assistance device that provides patients with warm, humidified, oxygen-enriched air through a nasal cannula. For example, in 2024, Fisher & Paykel Healthcare, a New Zealand-based manufacturer and marketer of products and systems for acute and chronic respiratory care, surgery, and obstructive sleep apnea treatment, introduced the Airvo 2 device as part of the Optiflow Nasal High Flow Therapy system. This device delivers heated, humidified air and oxygen at high flow rates, enhancing oxygenation and reducing the work of breathing for patients suffering from COVID-19 and other respiratory ailments. Its optimal humidity levels support mucociliary function and decrease airway dryness, thus improving patient comfort. Furthermore, the device is designed for easy setup and use, making it appropriate for various hospital environments and contributing to better clinical outcomes.
In March 2024, Onymos, a US-based developer of a Features-as-a-Service platform, partnered with Vapotherm, Inc. for an undisclosed amount. Through this partnership, Onymos aims to support Vapotherm in building a secure, end-to-end Internet of Medical Things (IoMT) platform that enhances remote device connectivity, real-time data visualization, and device management capabilities for Vapotherm’s HVT 2 system and future respiratory care products. This collaboration is intended to strengthen Vapotherm’s digital infrastructure, enabling improved monitoring, operational efficiency, and scalability across connected respiratory therapy devices. Vapotherm, Inc. is a US-based medical technology company specializing in high-velocity respiratory therapy solutions, including high-flow nasal cannula systems.
Major companies operating in the high flow nasal cannula market are Air Liquide Medical Systems Pvt. Ltd., Becton Dickinson and Company, Koninklijke Philips N.V., ResMed Inc., Drägerwerk AG & Co. KGaA, Teleflex Incorporated, Medical Dynamics Inc., Fisher & Paykel Healthcare Corporation Limited, Smiths Medical Inc., Vyaire Medical Inc., DeVilbiss Healthcare LLC, Armstrong Medical Ltd, Vapotherm Inc., SunMed LLC, Medin Medical Innovations GmbH, MEK-ICS Co. Ltd., Narang Medical Limited, Breas Medical AB, Bio-Med Devices Inc., Flexicare Medical Ltd., Fairmont Medical Products Pty Ltd, Besmed Health Business Corp., Löwenstein GmbH & Co. KG, Great Group Medical Co. Ltd., TNI Medical AG, Guangdong Pigeon Medical Apparatus Co.LTD, BLS Systems Limited.
North America was the largest region in the high flow nasal cannula market in 2025. The regions covered in the high flow nasal cannula market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the high flow nasal cannula market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the high-flow nasal cannula market by increasing costs of imported electronic controllers, sensors, heating elements, humidification chambers, and medical-grade plastics used in device manufacturing. Hospitals and care facilities in North America and Europe are most affected due to dependence on imported components, while Asia-Pacific faces pricing pressure on export-driven production. These tariffs are raising equipment acquisition costs and impacting procurement budgets. At the same time, they are encouraging regional manufacturing, local assembly of respiratory devices, and innovation in cost-optimized HFNC system designs.
The high flow nasal cannula market research report is one of a series of new reports that provides high flow nasal cannula market statistics, including high flow nasal cannula industry global market size, regional shares, competitors with a high flow nasal cannula market share, detailed high flow nasal cannula market segments, market trends and opportunities, and any further data you may need to thrive in the high flow nasal cannula industry. This high flow nasal cannula market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A high-flow nasal cannula (HFNC) is a medical device designed for delivering a high flow of heated and humidified oxygen-enriched air to patients with respiratory conditions. It comprises a lightweight tube connected to a machine that regulates the flow of air and oxygen. The cannula, placed in the patient's nostrils, administers a continuous stream of warm and moistened air at a higher flow rate compared to traditional oxygen therapy methods.
The primary types of high-flow nasal cannulas include air or oxygen blenders, nasal cannulas, active humidifiers, single-heated tubes, and others. Air-oxygen blenders are medical devices that blend air and oxygen to deliver a precise combination of oxygen and air to patients experiencing breathing difficulties or undergoing anesthesia. These devices find applications in various medical conditions such as acute respiratory failure, chronic obstructive pulmonary disease (COPD), carbon monoxide toxicity, bronchiectasis, sleep apnea, among others. High-flow nasal cannulas are distributed through diverse sales channels, including direct channels, and are utilized by various end-users, including hospitals and clinics, ambulatory care centers, long-term care centers, and others.
The high-flow nasal cannula (HFNC) market consists of sales of flow generators, oxygen blenders, nasal prongs, and humidifiers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. High flow nasal cannula Market Characteristics
3. High flow nasal cannula Market Supply Chain Analysis
4. Global High flow nasal cannula Market Trends and Strategies
5. High flow nasal cannula Market Analysis of End Use Industries
7. Global High flow nasal cannula Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global High flow nasal cannula Total Addressable Market (TAM) Analysis for the Market
9. High flow nasal cannula Market Segmentation
10. High flow nasal cannula Market Regional and Country Analysis
11. Asia-Pacific High flow nasal cannula Market
12. China High flow nasal cannula Market
13. India High flow nasal cannula Market
14. Japan High flow nasal cannula Market
15. Australia High flow nasal cannula Market
16. Indonesia High flow nasal cannula Market
17. South Korea High flow nasal cannula Market
18. Taiwan High flow nasal cannula Market
19. South East Asia High flow nasal cannula Market
20. Western Europe High flow nasal cannula Market
21. UK High flow nasal cannula Market
22. Germany High flow nasal cannula Market
23. France High flow nasal cannula Market
24. Italy High flow nasal cannula Market
25. Spain High flow nasal cannula Market
26. Eastern Europe High flow nasal cannula Market
27. Russia High flow nasal cannula Market
28. North America High flow nasal cannula Market
29. USA High flow nasal cannula Market
30. Canada High flow nasal cannula Market
31. South America High flow nasal cannula Market
32. Brazil High flow nasal cannula Market
33. Middle East High flow nasal cannula Market
34. Africa High flow nasal cannula Market
36. High flow nasal cannula Market Competitive Landscape and Company Profiles
37. High flow nasal cannula Market Other Major and Innovative Companies
40. High flow nasal cannula Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
High flow nasal cannula Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses high flow nasal cannula market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for high flow nasal cannula? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The high flow nasal cannula market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Air Or Oxygen Blenders; Nasal Cannulas; Active Humidifier; Single Heated Tube; Other Types2) By Application: Acute Respiratory Failure; Chronic Obstructive Pulmonary Disease (COPD); Carbon Monoxide Toxicity; Bronchiectasis; Sleep Apnea; Other Applications
3) By Sales Channel: Direct Channel; Distribution Channel
4) By End-User: Hospitals and clinics; Ambulatory care centers; Long-term care centers; Other End-Users
Subsegments:
1) By Air or Oxygen Blenders: Manual Oxygen Blenders; Digital Oxygen Blenders2) By Nasal Cannulas: Adult Nasal Cannulas; Pediatric Nasal Cannulas
3) By Active Humidifier: Heated Active Humidifiers; Non-Heated Active Humidifiers
4) By Single Heated Tube: Single Heated Tubes For Adult Use; Single Heated Tubes For Pediatric Use
5) By Other Types: Disposable High Flow Nasal Cannulas; Non-Invasive Ventilation (NIV) Interfaces
Companies Mentioned: Air Liquide Medical Systems Pvt. Ltd.; Becton Dickinson and Company; Koninklijke Philips N.V.; ResMed Inc.; Drägerwerk AG & Co. KGaA; Teleflex Incorporated; Medical Dynamics Inc.; Fisher & Paykel Healthcare Corporation Limited; Smiths Medical Inc.; Vyaire Medical Inc.; DeVilbiss Healthcare LLC; Armstrong Medical Ltd; Vapotherm Inc.; SunMed LLC; Medin Medical Innovations GmbH; MEK-ICS Co. Ltd.; Narang Medical Limited; Breas Medical AB; Bio-Med Devices Inc.; Flexicare Medical Ltd.; Fairmont Medical Products Pty Ltd; Besmed Health Business Corp.; Löwenstein GmbH & Co. KG; Great Group Medical Co. Ltd.; TNI Medical AG; Guangdong Pigeon Medical Apparatus Co.LTD; BLS Systems Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this High flow nasal cannula market report include:- Air Liquide Medical Systems Pvt. Ltd.
- Becton Dickinson and Company
- Koninklijke Philips N.V.
- ResMed Inc.
- Drägerwerk AG & Co. KGaA
- Teleflex Incorporated
- Medical Dynamics Inc.
- Fisher & Paykel Healthcare Corporation Limited
- Smiths Medical Inc.
- Vyaire Medical Inc.
- DeVilbiss Healthcare LLC
- Armstrong Medical Ltd
- Vapotherm Inc.
- SunMed LLC
- Medin Medical Innovations GmbH
- MEK-ICS Co. Ltd.
- Narang Medical Limited
- Breas Medical AB
- Bio-Med Devices Inc.
- Flexicare Medical Ltd.
- Fairmont Medical Products Pty Ltd
- Besmed Health Business Corp.
- Löwenstein GmbH & Co. KG
- Great Group Medical Co. Ltd.
- TNI Medical AG
- Guangdong Pigeon Medical Apparatus Co.LTD
- BLS Systems Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 6.79 Billion |
| Forecasted Market Value ( USD | $ 9.64 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |
